Model
Edge
Halozyme Therapeutics, Inc.
0001902866
Filing Type
4
Filing Date
2/23/2025
Updated
2/24/25, 3:07 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership